Diffusion-weighted whole-body MR imaging with background body signal suppression:: a feasibility study at 3.0 Tesla

被引:101
|
作者
Muertz, Petra
Krautmacher, Carsten
Traeber, Frank
Gieseke, Juergen
Schild, Hans H.
Willinek, Winfried A.
机构
[1] Univ Bonn, Dept Radiol, D-53105 Bonn, Germany
[2] Philips Med Syst, NL-5680DA Best, Netherlands
[3] Univ Bonn, Radiol Klin, D-53105 Bonn, Germany
关键词
Diffusion magnetic resonance imaging; Whole body imaging; High field; 3; 0; Tesla;
D O I
10.1007/s00330-007-0717-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The purpose was to provide a diffusion-weighted whole-body magnetic resonance (MR) imaging sequence with background body signal suppression (DWIBS) at 3.0 Tesla. A diffusion-weighted spin-echo echo-planar imaging sequence was combined with the following methods of fat suppression: short TI inversion recovery (STIR), spectral attenuated inversion recovery (SPAIR), and spectral presaturation by inversion recovery (SPIR). Optimized sequences were implemented on a 3.0- and a 1.5-Tesla system and evaluated in three healthy volunteers and six patients with various lesions in the neck, chest, and abdomen on the basis of reconstructed maximum intensity projection images. In one patient with metastases of malignant melanoma, DWIBS was compared with F-18-fluorodeoxyglucose positron emission tomography (FDG-PET). Good fat suppression for all regions and diagnostic image quality in all cases could be obtained at 3.0 Tesla with the STIR method. In comparison with 1.5 Tesla, DWIBS images at 3.0 Tesla were judged to provide a better lesion-to-bone tissue contrast. However, larger susceptibility-induced image distortions and signal intensity losses, stronger blurring artifacts, and more pronounced motion artifacts degraded the image quality at 3.0 Tesla. A good correlation was found between the metastases as depicted by DWIBS and those as visualized by FDG-PET. DWIBS is feasible at 3.0 Tesla with diagnostic image quality.
引用
收藏
页码:3031 / 3037
页数:7
相关论文
共 50 条
  • [31] Loco-regional radiotherapy targeting for oligo-progressive CRPC on the diffusion-weighted whole-body imaging with background body signal suppression (DWIBS)
    Yoshida, Soichiro
    Takahara, Taro
    Ishii, Chikako
    Nakagawa, Keiko
    Toda, Kazuma
    Kijima, Toshiki
    Yokoyama, Minato
    Ishioka, Junichiro
    Matsuoka, Yoh
    Saito, Kazutaka
    Yoshimura, Ryoichi
    Kihara, Kazunori
    Fujii, Yasuhisa
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 : 358 - 358
  • [32] Diffusion-weighted whole-body magnetic resonance imaging with background body signal suppression/T2 image fusion for the diagnosis of acute cholecystitis
    Tomizawa, Minoru
    Shinozaki, Fuminobu
    Tanaka, Satomi
    Sunaoshi, Takafumi
    Kano, Daisuke
    Sugiyama, Eriko
    Shite, Misaki
    Haga, Ryouta
    Fukamizu, Yoshiya
    Fujita, Toshiyuki
    Kagayama, Satoshi
    Hasegawa, Rumiko
    Shirai, Yoshinori
    Motoyoshi, Yasufumi
    Sugiyama, Takao
    Yamamoto, Shigenori
    Ishige, Naoki
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (01) : 730 - 734
  • [33] Diagnostic accuracy of diffusion-weighted whole-body imaging with background body signal suppression/T2-weighted image fusion for the detection of abdominal solid cancer
    Tomizawa, Minoru
    Shinozaki, Fuminobu
    Fugo, Kazunori
    Tanaka, Satomi
    Sunaoshi, Takafumi
    Kano, Daisuke
    Sugiyama, Eriko
    Shite, Misaki
    Haga, Ryouta
    Fukamizu, Yoshiya
    Fujita, Toshiyuki
    Kagayama, Satoshi
    Hasegawa, Rumiko
    Togawa, Akira
    Shirai, Yoshinori
    Ichiki, Noboru
    Oshima, Yuji
    Koike, Naoto
    Toshimitsu, Yasuko
    Motoyoshi, Yasufumi
    Sugiyama, Takao
    Yamamoto, Shigenori
    Kishimoto, Takashi
    Ishige, Naoki
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (06) : 3509 - 3515
  • [34] Stereotactic Body Radiotherapy for a Sacral Metastasis Clarified by Diffusion-Weighted Whole-Body Imaging With Background Body Signal Suppression in a Patient With Castration-Resistant Prostate Cancer
    Katano, Atsuto
    Takeuchi, Kenta
    Yamashita, Hideomi
    Nakagawa, Keiichi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (03)
  • [35] Accuracy and diagnostic value of diffusion-weighted whole body imaging with background body signal suppression (DWIBS) in metastatic breast cancer
    Mohamed Gaber Eissawy
    Amr M. Ismaeel Saadawy
    Kamel Farag
    Tamer Akl
    Wael Hamza Kamr
    Egyptian Journal of Radiology and Nuclear Medicine, 52
  • [36] Whole-body magnetic resonance imaging (WB-MRI) with diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) in prostate cancer: Prevalence and clinical significance o incidental findings
    Kumasaka, Soma
    Motegi, Shunichi
    Kumasaka, Yuka
    Nishikata, Tatsuya
    Otomo, Masami
    Tsushima, Yoshito
    BRITISH JOURNAL OF RADIOLOGY, 2022, 95 (1131):
  • [37] Accuracy and diagnostic value of diffusion-weighted whole body imaging with background body signal suppression (DWIBS) in metastatic breast cancer
    Eissawy, Mohamed Gaber
    Saadawy, Amr M. Ismaeel
    Farag, Kamel
    Akl, Tamer
    Kamr, Wael Hamza
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2021, 52 (01):
  • [38] Diffusion-weighted MR imaging with background body signal suppression (DWIBS) for the diagnosis of malignant and benign breast lesions
    Andreas Stadlbauer
    Reinhard Bernt
    Stephan Gruber
    Wolfgang Bogner
    Katja Pinker
    Wilma van der Riet
    Jörg Haller
    Erich Salomonowitz
    European Radiology, 2009, 19 : 2349 - 2356
  • [39] Diffusion-weighted MR imaging with background body signal suppression (DWIBS) for the diagnosis of malignant and benign breast lesions
    Stadlbauer, Andreas
    Bernt, Reinhard
    Gruber, Stephan
    Bogner, Wolfgang
    Pinker, Katja
    van der Riet, Wilma
    Haller, Joerg
    Salomonowitz, Erich
    EUROPEAN RADIOLOGY, 2009, 19 (10) : 2349 - 2356
  • [40] Whole-Body Diffusion-weighted MR Imaging in Cancer: Current Status and Research Directions
    Padhani, Anwar R.
    Koh, Dow-Mu
    Collins, David J.
    RADIOLOGY, 2011, 261 (03) : 700 - 718